MESO
Mesoblast limited.

5,290
Mkt Cap
$1.84B
Volume
170,848.00
52W High
$22.00
52W Low
$9.61
PE Ratio
-16.93
MESO Fundamentals
Price
$14.32
Prev Close
$14.85
Open
$15.07
50D MA
$16.46
Beta
1.42
Avg. Volume
240,375.78
EPS (Annual)
-$0.8443
P/B
3.07
Rev/Employee
$211,960.04
Loading...
Loading...
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
81

Frequently Asked Questions

What is Market Cap of Mesoblast Ltd - ADR?
What is the 52-week high for Mesoblast Ltd - ADR?
What is the 52-week low for Mesoblast Ltd - ADR?
What is Mesoblast Ltd - ADR stock price today?
What was Mesoblast Ltd - ADR stock price yesterday?
What is the PE ratio of Mesoblast Ltd - ADR?
What is the Price-to-Book ratio of Mesoblast Ltd - ADR?
What is the 50-day moving average of Mesoblast Ltd - ADR?
How many employess does Mesoblast Ltd - ADR has?

Latest MESO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.